The use of liposomal anthracyclines was strongly suggested as a therapeutic option for breast cancer patients. The authors concluded that this report was the first to produce a set of statements on the prevention, evaluation and monitoring of chemotherapy-induced cardiac toxicity in breast cancer patie...